Promega seeks to stop unlawful Benitec licensing activities of ddRNAi technology(12 Nov 2004) To protect its exclusive licensing rights, Promega filed a motion to stop Benitec from further licensing activities of ddRNAi technology in the areas which have been granted exclusively to Promega. Filing with the United States District Court for ...
Borean Pharma Appoints Dr. Johanna Holldack as Chief Operating Officer(10 Oct 2003) Appointment reflects Borean Pharma`s progress towards the execution of its business strategy of partnering and licensing Borean Pharma today announced the appointment of Johanna Holldack, M.D., as Chief Operating Officer. With more than 13 years of experience in the pharmaceutical and biotech industries, Dr. Holldack has been responsible for the development and ...
Top
